How it should be taken
It comes as a solution for injection to be administered by a healthcare provider into the vein or into the large muscle.
Dosage & When it is to be taken
The recommended dose of elspar is 6, 000 International Units/mē intramuscularly (IM) or intravenously (IV) three times a week.
When it is not to be taken (Contraindications)
Contraindicated in patients with inflammation of pancreas and bleeding due to prior therapy with this medication and hypersensitivity.
Why it is prescribed (Indications)
This medication is an antineoplastic agent, prescribed for lymphocytic leukemia either alone or with other medications. It stops cancer cell growth.
Category C :
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Warnings and Precautions
Caution should be exercised in patients with history of liver, kidney or pancreatic disease, any allergy, who are taking other medications, elderly, during pregnancy and breast-feeding.
It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
It may reduce platelet counts, avoid injury or bruising.
Avoid any vaccination during the treatment period.
Normally handled and stored by healthcare providers.